MDimune announced a joint research agreement with YiPSCELL to develop BioDrone® Platform therapeutics based on iPSCs.
[MDimune (EIN Presswire, Inc.)]
Sorry, but the selected Zotpress account can't be found.
Home Newsletters ESC & iPSC News MDimune Signs Research Agreement with YiPSCELL to Develop iPSC-Based BioDrone® Therapeutics
